207 related articles for article (PubMed ID: 2143498)
1. Myelopoiesis-associated suppressor-cell activity in mice with Lewis lung carcinoma tumors: interferon-gamma plus tumor necrosis factor-alpha synergistically reduce suppressor cell activity.
Young MR; Young ME; Wright MA
Int J Cancer; 1990 Aug; 46(2):245-50. PubMed ID: 2143498
[TBL] [Abstract][Full Text] [Related]
2. Myelopoiesis-associated immune suppressor cells in mice bearing metastatic Lewis lung carcinoma tumors: gamma interferon plus tumor necrosis factor alpha synergistically reduces immune suppressor and tumor growth-promoting activities of bone marrow cells and diminishes tumor recurrence and metastasis.
Young MR; Wright MA
Cancer Res; 1992 Nov; 52(22):6335-40. PubMed ID: 1423279
[TBL] [Abstract][Full Text] [Related]
3. Increasing infiltration and activation of CD8+ tumor-infiltrating lymphocytes after eliminating immune suppressive granulocyte/macrophage progenitor cells with low doses of interferon gamma plus tumor necrosis factor alpha.
Young MR; McCloskey G; Wright MA; Pak AS
Cancer Immunol Immunother; 1994 Jan; 38(1):9-15. PubMed ID: 8299123
[TBL] [Abstract][Full Text] [Related]
4. The effect of recombinant murine interferon-gamma on the hematopoietic and immunological parameters of mice bearing metastatic Lewis lung carcinoma tumors.
Young MR; Young ME; Wepsic HT
Exp Hematol; 1988 May; 16(4):295-301. PubMed ID: 2966070
[TBL] [Abstract][Full Text] [Related]
5. Differential induction of hematopoiesis and immune suppressor cells in the bone marrow versus in the spleen by Lewis lung carcinoma variants.
Young MR; Aquino S; Young ME
J Leukoc Biol; 1989 Mar; 45(3):262-73. PubMed ID: 2522492
[TBL] [Abstract][Full Text] [Related]
6. Regulation of tumor-induced myelopoiesis and the associated immune suppressor cells in mice bearing metastatic Lewis lung carcinoma by prostaglandin E2.
Young MR; Young ME; Kim K
Cancer Res; 1988 Dec; 48(23):6826-31. PubMed ID: 2972359
[TBL] [Abstract][Full Text] [Related]
7. Effects of fish oil and corn oil diets on prostaglandin-dependent and myelopoiesis-associated immune suppressor mechanisms of mice bearing metastatic Lewis lung carcinoma tumors.
Young MR; Young ME
Cancer Res; 1989 Apr; 49(8):1931-6. PubMed ID: 2522813
[TBL] [Abstract][Full Text] [Related]
8. Treating tumor-bearing mice with low-dose gamma-interferon plus tumor necrosis factor alpha to diminish immune suppressive granulocyte-macrophage progenitor cells increases responsiveness to interleukin 2 immunotherapy.
Pak AS; Ip G; Wright MA; Young MR
Cancer Res; 1995 Feb; 55(4):885-90. PubMed ID: 7850804
[TBL] [Abstract][Full Text] [Related]
9. Hematopoiesis and suppressor bone marrow cells in mice bearing large metastatic Lewis lung carcinoma tumors.
Young MR; Newby M; Wepsic HT
Cancer Res; 1987 Jan; 47(1):100-5. PubMed ID: 2947676
[TBL] [Abstract][Full Text] [Related]
10. Antibodies to colony-stimulating factors block Lewis lung carcinoma cell stimulation of immune-suppressive bone marrow cells.
Young MR; Wright MA; Young ME
Cancer Immunol Immunother; 1991; 33(3):146-52. PubMed ID: 1675153
[TBL] [Abstract][Full Text] [Related]
11. The suppressive effects of recombinant human tumor necrosis factor-alpha on normal and malignant myelopoiesis: synergism with interferon-gamma.
Herrmann F; Bambach T; Bonifer R; Lindemann A; Riedel D; Oster W; Mertelsmann R
Int J Cell Cloning; 1988 Jul; 6(4):241-61. PubMed ID: 3138311
[TBL] [Abstract][Full Text] [Related]
12. The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma.
Broxmeyer HE; Williams DE; Lu L; Cooper S; Anderson SL; Beyer GS; Hoffman R; Rubin BY
J Immunol; 1986 Jun; 136(12):4487-95. PubMed ID: 3086433
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of immune-suppressive bone marrow cells by colony-stimulating factors.
Young MR; Young ME; Wright MA
Exp Hematol; 1990 Aug; 18(7):806-11. PubMed ID: 2143138
[TBL] [Abstract][Full Text] [Related]
14. Suppression of T cell proliferation by tumor-induced granulocyte-macrophage progenitor cells producing transforming growth factor-beta and nitric oxide.
Young MR; Wright MA; Matthews JP; Malik I; Prechel M
J Immunol; 1996 Mar; 156(5):1916-22. PubMed ID: 8596044
[TBL] [Abstract][Full Text] [Related]
15. Ineffective immune enhancement by IL-12 in tumor-bearing mice whose immune depression is mediated by suppressive granulocyte-macrophage progenitor cells.
Prechel MM; Lozano Y; Wright MA; Ihm J; Young MR
Cancer Lett; 1995 Jun; 92(2):235-42. PubMed ID: 7600536
[TBL] [Abstract][Full Text] [Related]
16. Suppressive biological activity of a synthetic pentapeptide on highly enriched human and murine marrow hematopoietic progenitors: synergism with recombinant human tumor necrosis factor-alpha and interferon-gamma.
Lu L; Foa P; Chillemi F; Shen RN; Lin ZH; Carow C; Broxmeyer HE
Exp Hematol; 1989 Oct; 17(9):935-41. PubMed ID: 2506072
[TBL] [Abstract][Full Text] [Related]
17. 1 alpha,25-dihydroxyvitamin D3 plus gamma-interferon blocks lung tumor production of granulocyte-macrophage colony-stimulating factor and induction of immunosuppressor cells.
Young MR; Halpin J; Wang J; Wright MA; Matthews J; Pak AS
Cancer Res; 1993 Dec; 53(24):6006-10. PubMed ID: 8261414
[TBL] [Abstract][Full Text] [Related]
18. Differential induction of suppressor macrophages by cloned Lewis lung carcinoma variants in mice.
Young MR; Newby M
J Natl Cancer Inst; 1986 Dec; 77(6):1255-60. PubMed ID: 3491925
[TBL] [Abstract][Full Text] [Related]
19. Natural killer (NK) cell-derived hematopoietic colony-inhibiting activity and NK cytotoxic factor. Relationship with tumor necrosis factor and synergism with immune interferon.
Degliantoni G; Murphy M; Kobayashi M; Francis MK; Perussia B; Trinchieri G
J Exp Med; 1985 Nov; 162(5):1512-30. PubMed ID: 3932579
[TBL] [Abstract][Full Text] [Related]
20. Potentiation of antitumor effects of tumor necrosis factor alpha and interferon gamma by macrophage-colony-stimulating factor in a MmB16 melanoma model in mice.
Lasek W; Wańkowicz A; Kuc K; Feleszko W; Gołab J; Giermasz A; Wiktor-Jedrzejczak W; Jakóbisiak M
Cancer Immunol Immunother; 1995 May; 40(5):315-21. PubMed ID: 7600564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
